Immunological changes and prevention of disease progression through elotuzumab therapy in refractory IgG4-related sclerosing mesenteritis

Sara Comdühr; Alexander Dübbers; Lars Tharun; Hanna Graßhoff; John Stone; Silke Pitann; Gabriela Riemekasten; Peter Lamprecht

doi:10.1093/rheumatology/keac302

Immunological changes and prevention of disease progression through elotuzumab therapy in refractory IgG4-related sclerosing mesenteritis

Sara Comdühr^*, Alexander Dübbers, Lars Tharun, Hanna Graßhoff, John Stone, Silke Pitann, Gabriela Riemekasten, Peter Lamprecht

^*Corresponding author for this work

Harvard University

1 Citation (Scopus)

Original language	English
Journal	Rheumatology (United Kingdom)
Volume	61
Issue number	11
Pages (from-to)	E334-E336
ISSN	1462-0324
DOIs	https://doi.org/10.1093/rheumatology/keac302
Publication status	Published - 01.11.2022

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/rheumatology/keac302

Cite this

@article{60f02403761f4f4eacaa31334b028e6e,

title = "Immunological changes and prevention of disease progression through elotuzumab therapy in refractory IgG4-related sclerosing mesenteritis",

author = "Sara Comd{\"u}hr and Alexander D{\"u}bbers and Lars Tharun and Hanna Gra{\ss}hoff and John Stone and Silke Pitann and Gabriela Riemekasten and Peter Lamprecht",

year = "2022",

month = nov,

day = "1",

doi = "10.1093/rheumatology/keac302",

language = "English",

volume = "61",

pages = "E334--E336",

journal = "Rheumatology (United Kingdom)",

issn = "1462-0324",

number = "11",

}

TY - JOUR

T1 - Immunological changes and prevention of disease progression through elotuzumab therapy in refractory IgG4-related sclerosing mesenteritis

AU - Comdühr, Sara

AU - Dübbers, Alexander

AU - Tharun, Lars

AU - Graßhoff, Hanna

AU - Stone, John

AU - Pitann, Silke

AU - Riemekasten, Gabriela

AU - Lamprecht, Peter

PY - 2022/11/1

Y1 - 2022/11/1

UR - http://www.scopus.com/inward/record.url?scp=85141888313&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/keac302

DO - 10.1093/rheumatology/keac302

M3 - Letters

C2 - 35595249

AN - SCOPUS:85141888313

SN - 1462-0324

VL - 61

SP - E334-E336

JO - Rheumatology (United Kingdom)

JF - Rheumatology (United Kingdom)

IS - 11

ER -

Immunological changes and prevention of disease progression through elotuzumab therapy in refractory IgG4-related sclerosing mesenteritis

Research Areas and Centers

UN SDGs

Access to Document

Other files and links

Cite this